A PROBLEM SHARED IS A PROBLEM HALVED
By investing USD 30 million over five years, the Lilly NCD Partnership researches new and comprehensive approaches to fighting NCDs, reports on what works and what doesn’t, and advocates for the best solutions.
We work with global and national health organizations in Brazil, India, Mexico and South Africa to identify needs and develop effective programs that can make sustainable improvements in health outcomes.
Throughout the Lilly NCD Partnership, we explore numerous possibilities to determine where we could have the most impact and which partners are the best match. We’re very pleased with where the process has led and feel confident that the partnership is set for success.